"bms" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonBMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech
BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology
BMS expands CAR-T portfolio with $1.5bn Orbital buyout Pharmaceutical Technology
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push - Reuters
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push Reuters
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbit...
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics Business Wire
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover BioSpace
BMS latest to enter in vivo CAR-T field with $1.5B Orbital buy - FirstWord Pharma
BMS latest to enter in vivo CAR-T field with $1.5B Orbital buy FirstWord Pharma
BMS Ascends To In Vivo CAR-T Market With Orbital Buy - insights.citeline.com
BMS Ascends To In Vivo CAR-T Market With Orbital Buy insights.citeline.com
Bristol Myers Squibb Moves Into In Vivo CAR T with $1.5 Billion Orbital Buy - Inside Precision Me...
Bristol Myers Squibb Moves Into In Vivo CAR T with $1.5 Billion Orbital Buy Inside Precision Medicine
Bristol Myers Squibb to Acquire Orbital Therapeutics for $1.5B - New Jersey Business & Industry A...
Bristol Myers Squibb to Acquire Orbital Therapeutics for $1.5B New Jersey Business & Industry Association
CAR Ts for autoimmune ramp up: BMS buying Orbital for $1.5B - BioWorld MedTech
CAR Ts for autoimmune ramp up: BMS buying Orbital for $1.5B BioWorld MedTech
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics - Ph...
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics Pharmaceutical Executive
Bristol Myers Squibb agrees to buy Orbital Therapeutics to bolster cell therapy portfolio - ROI-NJ
Bristol Myers Squibb agrees to buy Orbital Therapeutics to bolster cell therapy portfolio ROI-NJ
BMS builds in 'in vivo' cell therapy with $1.5bn Orbital buy - Pharmaphorum
BMS builds in 'in vivo' cell therapy with $1.5bn Orbital buy Pharmaphorum
Bristol Myers Squibb to Acquire Orbital Therapeutics - Contract Pharma
Bristol Myers Squibb to Acquire Orbital Therapeutics Contract Pharma
Bristol Myers Squibb to buy RNA start-up for $1.5 billion - Chemical & Engineering News
Bristol Myers Squibb to buy RNA start-up for $1.5 billion Chemical & Engineering News
Bristol Myers Squibb to buy Orbital Therapeutics for $1.5B - Axios
Bristol Myers Squibb to buy Orbital Therapeutics for $1.5B Axios
Bristol Myers Squibb, NCPA pilot rural healthcare initiative - Drug Store News
Bristol Myers Squibb, NCPA pilot rural healthcare initiative Drug Store News
Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer t...
Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test Fierce Biotech
Ono's BMS-partnered oral gastric cancer drug tastes mid-stage success - FirstWord Pharma
Ono's BMS-partnered oral gastric cancer drug tastes mid-stage success FirstWord Pharma
Become a business supplier - Bristol Myers Squibb
Become a business supplier Bristol Myers Squibb
Bristol Myers Squibb to acquire Orbital for $1.5B - NJBIZ
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative ...
Multifunctional nanostructured lipid carriers encapsulating Bacillus megaterium supernatant and m...
BMS and Price Forbes win major public entity deals from Howden - Insurance Insider US
BMS and Price Forbes win major public entity deals from Howden Insurance Insider US
Bristol Myers Squibb and TV host Gail Simmons tackle stigma in schizophrenia with new initiative ...
Bristol Myers Squibb and TV host Gail Simmons tackle stigma in schizophrenia with new initiative PharmaLive
Bristol Myers Squibb buys Cambridge biotech for $1.5B - The Business Journals
Bristol Myers Squibb buys Cambridge biotech for $1.5B The Business Journals
BMS President named finalist for community champion award - Kingsport Times News
BMS President named finalist for community champion award Kingsport Times News
BMS lands Howden director Wilkinson - Insurance Insider US
BMS lands Howden director Wilkinson Insurance Insider US
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients Fierce Pharma
WV potentially paid $32M to provide Medicaid to ineligible people, including some who were deceas...
WV potentially paid $32M to provide Medicaid to ineligible people, including some who were deceased West Virginia Watch
Bristol Myers Squibb to buy Orbital Therapeutics for $1.5B in cash (BMY:NYSE) - Seeking Alpha
Bristol Myers Squibb to buy Orbital Therapeutics for $1.5B in cash (BMY:NYSE) Seeking Alpha
Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb
Doctorx Unscripted Bold Conversations about Patient-Driven Science Bristol Myers Squibb
Independent research - Bristol Myers Squibb
Independent research Bristol Myers Squibb
BMS runners shine at district championship meet - Bandera Bulletin
BMS runners shine at district championship meet Bandera Bulletin
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma Fierce Biotech
Chris Shibutani, MD - Bristol Myers Squibb
Chris Shibutani, MD Bristol Myers Squibb
BMS to speak with regulators on mid-stage multiple myeloma success - Clinical Trials Arena
BMS to speak with regulators on mid-stage multiple myeloma success Clinical Trials Arena
New battery simulator module simplifies and accelerates BMS test - Electropages
New battery simulator module simplifies and accelerates BMS test Electropages
Battery Show: Pickering 5-amp battery simulator speeds up BMS testing - Tech Briefs
Battery Show: Pickering 5-amp battery simulator speeds up BMS testing Tech Briefs
Global Inclusion & Diversity - Bristol Myers Squibb
Global Inclusion & Diversity Bristol Myers Squibb
NCPA launches pilot with Bristol Myers Squibb to address cardiovascular disease in rural communit...
NCPA launches pilot with Bristol Myers Squibb to address cardiovascular disease in rural communities HME News
The Bristol Myers Squibb Foundation - Bristol Myers Squibb
The Bristol Myers Squibb Foundation Bristol Myers Squibb
Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play - ts2.tech
Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play ts2.tech
Worldwide locations - Bristol Myers Squibb
Worldwide locations Bristol Myers Squibb
Areas of interest - Bristol Myers Squibb
Areas of interest Bristol Myers Squibb
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy Fierce Pharma
Our research in neuroscience - Bristol Myers Squibb
Our research in neuroscience Bristol Myers Squibb
People and business resource groups - Bristol Myers Squibb
People and business resource groups Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
Our research in immunology - Bristol Myers Squibb
Our research in immunology Bristol Myers Squibb
About us - Bristol Myers Squibb
About us Bristol Myers Squibb
Pickering launches new 5A PXI battery simulator module for advanced BMS testing - Charged EVs
Pickering launches new 5A PXI battery simulator module for advanced BMS testing Charged EVs
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs Bristol Myers Squibb
Transparency & reporting - Bristol Myers Squibb
Transparency & reporting Bristol Myers Squibb
Bristol-Myers Squibb: Your Chance To Buy A Bargain 6% Yield (NYSE:BMY) - Seeking Alpha
Bristol-Myers Squibb: Your Chance To Buy A Bargain 6% Yield (NYSE:BMY) Seeking Alpha
Clinical trials & studies - Bristol Myers Squibb
Clinical trials & studies Bristol Myers Squibb
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price - Reuters
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price Reuters
BMS sells controlling stake in historic US-China pharmaceutical joint venture - Fierce Pharma
BMS sells controlling stake in historic US-China pharmaceutical joint venture Fierce Pharma
Expanding access to lung cancer screening - Bristol Myers Squibb
Expanding access to lung cancer screening Bristol Myers Squibb
Business development leadership team - Bristol Myers Squibb
Business development leadership team Bristol Myers Squibb
In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles - Fierce Pharma
In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles Fierce Pharma
Post study drug access to BMS investigational medicinal products and approved products - Bristol ...
Post study drug access to BMS investigational medicinal products and approved products Bristol Myers Squibb
Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva
Research and development center Cambridge, Massachusetts - Bristol Myers Squibb
Research and development center Cambridge, Massachusetts Bristol Myers Squibb
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C Bristol Myers Squibb
BMS’ Phase III trial of Reblozyl misses primary endpoint - Clinical Trials Arena
BMS’ Phase III trial of Reblozyl misses primary endpoint Clinical Trials Arena
Our impact - Bristol Myers Squibb
Our impact Bristol Myers Squibb
BMS-986446 Granted Fast Track Designation for the Treatment of Alzheimer Disease - Psychiatric Times
BMS-986446 Granted Fast Track Designation for the Treatment of Alzheimer Disease Psychiatric Times
Pre-approval access to investigational medicines - Bristol Myers Squibb
Pre-approval access to investigational medicines Bristol Myers Squibb
Our science - Bristol Myers Squibb
Our science Bristol Myers Squibb
Annual reports - Bristol Myers Squibb
Annual reports Bristol Myers Squibb
2025 Annual Meeting of Shareholders - Bristol Myers Squibb
2025 Annual Meeting of Shareholders Bristol Myers Squibb
Looking to the Future of Cell Therapy - Bristol Myers Squibb
Looking to the Future of Cell Therapy Bristol Myers Squibb
Science Firsthand: The pathway to drug discovery - Bristol Myers Squibb
Science Firsthand: The pathway to drug discovery Bristol Myers Squibb
Women innovators in AI transforming patient care - Bristol Myers Squibb
Women innovators in AI transforming patient care Bristol Myers Squibb
Groupe Beneteau Acquires BMS to Enhance Mediterranean Services - Pressmare
Groupe Beneteau Acquires BMS to Enhance Mediterranean Services Pressmare
UK under pressure as BMS sets US-level price for schizophrenia drug - Financial Times
UK under pressure as BMS sets US-level price for schizophrenia drug Financial Times
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis - Fierce Pharma
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis Fierce Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation FirstWord Pharma
Why partner with us - Bristol Myers Squibb
Why partner with us Bristol Myers Squibb
Advanced battery diagnostics for electric vehicles using CAN based BMS data with EKF and data dri...
Science Firsthand: Predicting new possibilities in drug discovery - Bristol Myers Squibb
Science Firsthand: Predicting new possibilities in drug discovery Bristol Myers Squibb
Female BMS Students Take a Tour of A.K. Smith Career Center - GreatNews.Life
Female BMS Students Take a Tour of A.K. Smith Career Center GreatNews.Life
Protein homeostasis 101: A Q&A with Mark Rolfe - Bristol Myers Squibb
Protein homeostasis 101: A Q&A with Mark Rolfe Bristol Myers Squibb
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC Fierce Biotech
BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial - Clinical Tria...
BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial Clinical Trials Arena
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set pha...
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose Fierce Biotech
BMS ups guidance, but its financial prospects fail to capture investor enthusiasm - FirstWord Pharma
BMS ups guidance, but its financial prospects fail to capture investor enthusiasm FirstWord Pharma
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US FirstWord Pharma
New 5 Amp battery simulator module simplifies and accelerates BMS test - New Electronics
New 5 Amp battery simulator module simplifies and accelerates BMS test New Electronics
Global Automotive BMS Market Set for Dynamic Growth: 2025 Estimates & 2030 Projections - Yahoo Fi...
Global Automotive BMS Market Set for Dynamic Growth: 2025 Estimates & 2030 Projections Yahoo Finance
Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb
Science Firsthand: Translating the promise of cell therapy Bristol Myers Squibb
Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program - Fierce Pharma
Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program Fierce Pharma
Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless - BioSpace
Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless BioSpace
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel UroToday
BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding - Fierce Biotech
BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding Fierce Biotech
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designati...
Indonesian Officials Find Cause of Cs-137 Contamination Behind Radioactive Shrimp - Food Safety M...
Indonesian Officials Find Cause of Cs-137 Contamination Behind Radioactive Shrimp Food Safety Magazine
BMS and Bain Capital forge $300m immunology spinoff - Pharmaceutical Technology
BMS and Bain Capital forge $300m immunology spinoff Pharmaceutical Technology
BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma
BMS, Bain Capital team up on autoimmune-focused newco FirstWord Pharma